Kangji Medical Holdings Ltd
HKEX:9997
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.01
8.15
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Kangji Medical Holdings Ltd
Selling, General & Administrative
Kangji Medical Holdings Ltd
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
K
|
Kangji Medical Holdings Ltd
HKEX:9997
|
Selling, General & Administrative
-ÂĄ171.2m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Selling, General & Administrative
-ÂĄ3.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
||
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Selling, General & Administrative
-ÂĄ364.8m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-4%
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Selling, General & Administrative
-ÂĄ1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
||
Winner Medical Co Ltd
SZSE:300888
|
Selling, General & Administrative
-ÂĄ2.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
||
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Selling, General & Administrative
-ÂĄ686.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
Kangji Medical Holdings Ltd
Glance View
Kangji Medical Holdings Ltd., nestled in the bustling backdrop of China's thriving medical device industry, has carved a niche for itself in the realm of minimally invasive surgery (MIS). Since its inception, the company has focused on designing and manufacturing a range of surgical tools and devices that cater specifically to MIS procedures. These procedures, which include general surgery, gynecology, and urology, are gaining popularity due to their reduced recovery times and lower risk factors compared to traditional surgery. Kangji Medical leverages its robust R&D capabilities and intimate understanding of physicians' needs to deliver high-quality, ergonomic instruments that enhance operational precision and patient outcomes. The lifeblood of Kangji Medical lies in its strategic manufacturing and marketing prowess, enabling it to maintain a solid foothold in the competitive landscape. By keeping its production chain streamlined and efficient, the company achieves significant cost advantages, which in turn translates to competitive pricing. These savings are reinvested in expanding its product portfolio and enhancing technological innovations, thus ensuring a constant edge over its peers. Moreover, Kangji's astute distribution networks and partnerships with leading hospitals enable it to secure a steady demand flow for its products. This strategy has not only facilitated steady revenue growth but also ensured Kangji's reputation as a reliable contributor to the advancing field of minimally invasive surgical procedures.
See Also
What is Kangji Medical Holdings Ltd's Selling, General & Administrative?
Selling, General & Administrative
-171.2m
CNY
Based on the financial report for Dec 31, 2023, Kangji Medical Holdings Ltd's Selling, General & Administrative amounts to -171.2m CNY.
What is Kangji Medical Holdings Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-28%
Over the last year, the Selling, General & Administrative growth was -39%. The average annual Selling, General & Administrative growth rates for Kangji Medical Holdings Ltd have been -11% over the past three years , -28% over the past five years .